Skip to content
value.today

Proxim Diagnostics Corp

Total raised
$22 M
3 rounds on record
Latest round
$18 M
Nov 2022
First round on record
Feb 2016
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Proxim Diagnostics Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2022$18 MNo. 3$10 to $50 million

Proxim Diagnostics Corp: Raise no. 3, Nov 2022

Investors in this round

1 investor had bought by the notice of Nov 29, 2022: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $18 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mikhail Briman · Executive Officer, Director
  • Sergey Belonozhko · Director
  • Thomas Shannon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mikhail Briman, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 29, 2022. Read the notice at the SEC.

equitySEC
Sep 2018$2 MNo. 2Under $2 million

Proxim Diagnostics Corp: Raise no. 2, Sep 2018

Investors in this round

8 investors had bought by the notice of Oct 2, 2018: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $10 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mikhail Briman · Executive Officer, Director
  • Sergey Belonozhko · Director
  • Thomas Shannon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mikhail Briman, Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 2, 2018. Read the notice at the SEC.

equitySEC
Feb 2016$2 MNo. 1$2 to $10 million

Proxim Diagnostics Corp: Raise no. 1, Feb 2016

Investors in this round

12 investors had bought by the notice of Mar 11, 2016: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mikhail Briman · Executive Officer, Director
  • Vikram Joshi · Executive Officer
  • Andy Shrago · Director
  • Sergey Belonozhko · Director
  • Thomas Shannon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Vikram Joshi, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 11, 2016. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Proxim Diagnostics Corp chose not to state its revenue in its newest notice of a funding round (Nov 2022).

    SEC Form D · Nov 2022

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Nov 2022

That is all the official record says: Proxim Diagnostics Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Proxim Diagnostics Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 12 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Proxim Diagnostics Corp
NameRoleNamed in
Mikhail BrimanExecutive officerNov 2022
Vikram JoshiExecutive officerMar 2016
Mikhail BrimanDirectorNov 2022
Sergey BelonozhkoDirectorNov 2022
Thomas ShannonDirectorNov 2022
Andy ShragoDirectorMar 2016